Related references
Note: Only part of the references are listed.Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma
Zhaolan Xiang et al.
AGING-US (2020)
Discovery and validation of the prognostic value of the lncRNAs encoding snoRNAs in patients with clear cell renal cell carcinoma
Wuping Yang et al.
AGING-US (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Targeting claudin-4 enhances chemosensitivity in breast cancer
Yi Luo et al.
CANCER SCIENCE (2020)
Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC)
Shiyi Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu et al.
CANCER RESEARCH (2018)
Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis
Yifan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
CLDN10 is Associated with Papillary Thyroid Cancer Progression
Yili Zhou et al.
JOURNAL OF CANCER (2018)
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
S. Cherradi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
Prabhsimranjot Singh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer
Yutao Gao et al.
ONCOLOGY REPORTS (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Senbabaoglu et al.
GENOME BIOLOGY (2016)
Emerging Roles of Claudins in Human Cancer
Mi Jeong Kwon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease
Jean-Jacques Patard et al.
EUROPEAN UROLOGY (2011)
Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival
G. W. Huang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Transcriptional Regulation of Claudin-18 via Specific Protein Kinase C Signaling Pathways and Modification of DNA Methylation in Human Pancreatic Cancer Cells
Tatsuya Ito et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
Ugur Sahin et al.
CLINICAL CANCER RESEARCH (2008)
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells
Hiroshi Honda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Role of claudins in tumorigenesis
K Swisshelm et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Cell adhesion system and human cancer morphogenesis
S Hirohashi et al.
CANCER SCIENCE (2003)
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
NK Janzen et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Multifunctional strands in tight junctions
S Tsukita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)